Clinical Trial Update: Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (MetaDLM_CMT2A) [NA]

View source ↗

Summary

A completed clinical study exploring metabolomic changes and dysregulated lipid metabolism in MFN2-related Charcot-Marie-Tooth disease type 2A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 2a

Snippet

Sponsor: University Hospital, Angers | Conditions: Charcot-Marie-Tooth Disease Type 2A | NA | Status: COMPLETED